NEW
YORK, July 18, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law
firm, is investigating whether certain officers and directors of
Apellis Pharmaceuticals, Inc. (NASDAQ:
APLS) breached their fiduciary duties to
shareholders.
According to a federal securities lawsuit, Apellis insiders
caused the company to misrepresent or fail to disclose that (1) the
design of SYFOVRE's clinical trials was insufficient to identify
incidents of retinal vasculitis in patients receiving SYFOVRE
injections; (2) as a result, the commercial adoption of SYFOVRE was
subject to significant, unknown risk factors; and (3) therefore,
statements about the company's business, operations, and prospects
lacked a reasonable basis.
If you currently own Apellis and purchased prior to
January 28, 2021
please contact Justin Kuehn, Esq. by email
at justin@kuehn.law or call (833) 672-0814. The
consultation and case are free with no obligation to you.
Kuehn Law pays all case costs and
does not charge its investor clients. Shareholders should
contact the firm immediately as there may be limited time to
enforce your rights.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved,
you contribute to the integrity and fairness of the financial
markets. Your investment. Your voice. Your
future.™
For additional information, please visit Shareholder Derivative
Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar
outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download
multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-apellis-pharmaceuticals-inc-to-contact-law-firm-302201097.html
SOURCE Kuehn Law, PLLC